23andme - Search News

Order byBest matchMost fresh

23andMe, DNA

23andMe sold in bankruptcy: What it means for your DNA data

Biotech giant Regeneron announced Monday that it would acquire DNA testing company 23andMe for $256 million following a bankruptcy auction. The deal includes access to 23andMe's massive personal and genetic data trove from more than 15 million customers.

· 5h · on MSN

23andMe Sold To Biotechnology Company For $256 Million

· 14h · on MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

· 13h

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 15h

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

· 11h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

· 7h

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

Regeneron Pharmaceuticals said Monday it will acquire 23andMe’s DNA testing business and most of its assets out of bankruptcy and pledged to continue offering the popular consumer service and adopt it...

· 13h

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

· 15h

Biotechnology company Regeneron buying 23andMe for $256 million

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

14h

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

16h

A drug developer is buying 23andMe - what does that mean for your DNA data?

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

15hon MSN

23andMe sells gene-testing business to DNA drug maker Regeneron

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

Stock Movers: 23andMe, Reddit, Royal Caribbean

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Explore more

Regeneron

DNA

Biotechnology

23andMe, DNA

Related Searches